Immunosuppressive Properties of Calcium Channel Blockers
Authors:
- Karen L. Heim‐DuthoyKHKaren L. Heim‐Duthoy
- 10 September 1993
- journal article
- research article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 13 (5) , 447-454
Abstract
Calcium channel blockers are extensively used for their beneficial effects on the cardiovascular system. Solid organ transplant recipients commonly have cardiovascular disease and are often treated with these agents. Research demonstrates that calcium antagonists may have beneficial effects in this population that are independent of their effects on the cardiovascular system. Indeed, both in vitro and in vivo studies suggested that they may possess immunosuppressive properties. Their actions at the cellular level in both the afferent and efferent arms of the immune system indicate that alone, as well as in combination with cyclosporine, these agents possess immunosuppressive properties that may potentially benefit the transplant population.Keywords
This publication has 22 references indexed in Scilit:
- Clinical Pharmacokinetics of Calcium AntagonistsClinical Pharmacokinetics, 1992
- ADDITIVE INHIBITION OF AFFERENT AND EFFERENT IMMUNOLOGICAL RESPONSES OF HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS BY VERAPAMIL AND CYCLOSPORINETransplantation, 1991
- CYCLOSPORINE DOSE REDUCTION BY KETOCONAZOLE ADMINISTRATION IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1991
- Modulation of murine in vitro immune response by verapamil (V)Immunopharmacology, 1990
- EFFECTS OF CALCIUM CHANNEL BLOCKERS ON IN VIVO CELLULAR IMMUNITY IN MICETransplantation, 1989
- Nifedipine-induced hyporeactivity in delayed hypersensitivity skin testsInternational Journal of Immunopharmacology, 1987
- POTENTIATION OF CYCLOSPORINE BY VERAPAMIL IN VITROTransplantation, 1985
- Verapamil inhibition of lymphocyte proliferation and function in vitroJournal of Surgical Research, 1985
- Cyclosporin A Binding to Calmodulin: A Possible Site of Action on T LymphocytesScience, 1985
- Mechanism of Action of Calcium-Channel-Blocking AgentsNew England Journal of Medicine, 1982